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Infection with intracellular pathogens triggers cytokine production in the infected cells. In this issue of Immu-
nity, Kasper et al. (2010) demonstrate that in certain infections, much of the response is mounted by nonin-
fected neighboring cells.The epithelial surface is a key portal of
entry for pathogens. However, invading
pathogens are detected by pattern recog-
nition receptors (PRRs),which activate the
appropriate innate defenses (Ting et al.,
2010). Dependingon the typeand thecon-
text of stimulation, sensing of the path-
ogen could trigger the activation of inflam-
masome, which facilitates maturation and
secretion of preformed interleukin (IL)-1
family members and/or the expression of
antimicrobial compounds, chemokines,
and cytokines such as IL-8. The chemoat-
tractants recruit phagocytes to the site of
infection to facilitate pathogen elimination
and initiate adaptive immune responses.
The mucosal epithelium was regarded
as a passive element, contributing to
host defense mainly by forming an imper-
meable, tight-junction-fortified monolayer
prohibiting microbial access to the under-
lying tissue. This view has changed over
the past decade as it became clear that
epithelial cells express PRRs, including
the Nod-like receptors Nod1 and Nod2,
and that these PRRs recognize microbial
products leading to the secretion of proin-
flammatory cytokines (Artis, 2008; Ting
et al., 2010). Thus, infected epithelial cells
produce key cytokines (e.g., IL-8,
CXCL-2, TNF-a, GM-CSF), attract phago-cytic cells, and ultimately orchestrate
innate immune defense and initiate adap-
tive immunity (Eckmann and Kagnoff,
2005). Therefore, epithelia do play an
active role in coordinating defense.
Based on classical receptor-response
mechanisms, it has been assumed that
the proinflammatory cytokines are pro-
duced by the infected cell itself. This
made sense as each epithelial cell har-
bored the PRRand the signaling cascades
for driving cytokine expression. However,
in this issue of Immunity, Kasper et al.
(2010) demonstrate a substantial contribu-
tion of the response came from the nonin-
fected bystander cells. This study em-
ployed the invasive pathogen Shigella
flexneri to study signaling of the NF-kB
transcription factor pathway, as well as
JNK, ERK, and p38 kinase activation and
IL-8 secretion at the single cell level.
Upon invasion, S. flexneri enters the host
cell’s cytosol, where it is recognized by
Nod1, activating NF-kB, JNK-, and ERK
and p38 signaling and inducing IL-8 secre-
tion (Figure 1). Surprisingly, NF-kB, JNK,
ERK, and p38 signaling and IL-8 secretion
occurred not only in the infected cell itself
but also in the surrounding, noninfected
bystander cells. Notably, bystander acti-
vation occurred by 30 min of infectionand the cytokine release by the bystander
cells was even more pronounced than
that of the infected cell itself. Therefore,
the bystander cells amplified the defense
signal within the infected epithelium.
Bystander cell activation has also been
identified in a parallel study of the Gram-
positive pathogen Listeria monocytogenes
(Dolowschiak et al., 2010). Soon after this
pathogenhasreachedthecytosolofmurine
intestinal mICcl2 cells, the noninfected
bystander cells begin expressing the che-
mokines CXCL5 and CXCL2, a murine
IL-8 homolog (Figure 1). Notably, both
studies excluded the possibility that
bystander cells are activated by paracrine
signaling, e.g., by cytokines released from
the infected cells. Thus, bystander activa-
tion is a new mechanism of general impor-
tance for defense against various intracel-
lular pathogens.
It seems surprising that bystander cell
activation has not been observed earlier.
This is most likely linked to the types of
reagents and assays generally used in the
field. Most studies of innate immunity have
employed purified pathogen-derivedmole-
cules, an approach prohibiting differential
analysis of direct and indirect activation.
Single cell analysis of bacterial infection
has circumvented this technical problem.
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Figure 1. Bystander Activation Drives Epithelial Cytokine Responses
Shigella and Listeria spp. enter the host cell cytosol where cell wall components activate Nod1 or Nod2.
S. flexneri thereby elicits (unidentified) molecular signals, which are transmitted to noninfected bystander
cells via gap junctions. L. monocytogenes activates Nod2 and thereby Nox4, thus eliciting ROI, which are
sensed (in an unknown fashion) by the bystander cell. In both cases, bystander cells respond by NF-kB-,
JNK-, and p38-mediated cytokine production. Hence, the bulk of the cytokines are produced by nonin-
fected bystander cells.
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spreadandfluorescence techniques forde-
tecting infectedcells, noninfectedcells, and
host cellular activation were essential for
discovering bystander activation.
The mechanism of signal transmission
to the bystander cells is clearly of great
interest and may reshape current mecha-
nistic models of the cell biology of the
innate immune response. Here, the two
studiesoffer somewhatdivergent explana-
tions. In S. flexneri-infected human cells,
the signal was elicited by the PRR Nod1
and required gap junctions, small water
filled pores connecting neighboring
epithelial cells (Kasper et al., 2010). Lack
of expression or inhibition of gap junctions
crippled bystander activation. However,
the molecular nature of the activating
signal transmitted through the gap junc-
tions has not yet been identified (Figure 1).
In contrast, L. monocytogenes required
Nod2 for eliciting responses in murine
mICcl2 cells and bystander activation was
insensitive to gap junction inhibitors (Do-
lowschiak et al., 2010). Instead, bystander
activation depended on reactive oxygen
intermediates (ROIs; Figure 1). ROIs were
produced by the epithelium-encoded
NADPH oxidase Nox4. These ROIs werethen detected in bystander cells, and abla-
tion of ROI signaling by chemical inhibitors
or siRNAs abolished bystander activation.
Possibly, the differences in the proposed
mechanisms are explained by the different
nature of the host cells and of the patho-
gens which were investigated. However,
it is tempting to speculate that different
mechanisms of bystander cell activation
may exist that might be triggered by
different PRR. These will be important
topics for future research.
What are the potential benefits of
bystander cell activation? Clearly, signal
amplification by elevating the total cyto-
kine output per infection event represents
one plausible advantage. Alternatively,
bystander cell activation might represent
a ‘‘safeguard feature’’ ensuring a proper
defense, even if signaling in the infected
cell is subverted by an invading pathogen.
In fact, this has been demonstrated
elegantly for S. flexneri (Kasper et al.,
2010). This pathogen employs a type III
secretion system not only for triggering
epithelial cell invasion, but also for inject-
ing the virulence factor OspF into the
cytosol of the infected cell. OspF is
a potent inhibitor of JNK, ERK and p38
signaling, resulting in the inhibition ofImmunity 33, Nproinflammatory gene expression by the
infected cell (Li et al., 2007). Kasper
et al. (2010) could show that this effect is
restricted to the infected cell, whereas
bystander cell responses remained unaf-
fected. Moreover, IL-8 induction by
a S. flexneri ospF mutant was equivalent
in the infected and in the bystander cells.
Thus, bystander activation seems to
ensure defense even if cytokine produc-
tion of the infected cell is inhibited by the
pathogen. As pointed out by the authors
(Kasper et al., 2010), this provides a plau-
sible explanation for the puzzling obser-
vation that several mucosal pathogens
which elicit pronounced mucosal inflam-
mation, do express potent inhibitors of
NF-kB, JNK, ERK, and p38 signaling,
e.g., OspF and OspG from S. flexneri or
AvrA from Salmonella typhimurium (Jones
et al., 2008; Kim et al., 2005).
Are there virulence factors subverting
bystander cell activation? In the case of
S. flexneri, bystander cell activation
occurred with very high efficiency. In
contrast, L. monocytogenes and S. typhi-
muriumwere slightly less effective (Kasper
et al., 2010). The reasons for this are
currentlyunclear.However,onemayspec-
ulate that virulence factors dampening
bystander cell activation (via gap junctions
and/or ROI) might be involved. Stealthy
invasive pathogens like Chlamydia spp.
or Salmonella typhi, which can invade
epithelia without triggering pronounced
responses, might be a promising source
of such virulence factors. Again, this is
purely speculative. But the identification
of bystander cell activation has opened
the door for addressing this question.
So far, bystander cell activation has
been studied in tissue culture. It will be
important to probe its role in vivo during
the course of infection. PRR signaling,
which seems to be central to bystander
cell activation, is subject to regulation.
Desensitization of PRR responses has
been observed upon continued exposure
to microbial products (Foster et al., 2007;
Lotz et al., 2006). Similarly, bystander acti-
vation might be downregulated in the gut
or other microbe-exposed epithelia. In
this case, erroneous regulation of by-
stander activation might play a role in the
genesis of some inflammatory bowel
diseases. In addition, bystander activation
may occur in deeper tissues that are nor-
mally not exposed tomicrobes. Thiswould
be in linewith the observation of bystanderovember 24, 2010 ª2010 Elsevier Inc. 653
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and human umbilical vein endothelial cells
(Kasper et al., 2010). Systematic studies of
bystander activation in different infected
tissues will be of significant interest for
understanding bacterial pathogenesis
and host response to infection.
In conclusion, bystander cell activation
may shift the paradigm of epithelial cell
function in infectious disease. This mech-
anism transforms our view of the innate
immune response and may have a broad
relevance for innate immune defense
against intracellular pathogens. The direct
communication between infected and654 Immunity 33, November 24, 2010 ª2010noninfected cells of an infected tissue rai-
ses numerous questions for cell biology,
immunology, and bacterial pathogenesis.REFERENCES
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In this issue of Immunity, Bao et al. (2010) provide in vivo evidence that heparan sulfate glycosaminoglycans
(GAGs) are indispensable for immobilization and function of major chemokines required for leukocyte adhe-
sion to and crossing through blood and lymphatic vessels.Chemokines are structurally related che-
motactic cytokines (chemoattractants)
with remarkable functional versatility
(Bromley et al., 2008). Chemokines signal
through cognate G protein coupled
receptors (GPCRs) either at their soluble
or immobilized states. However, a direct
in vivo proof for their functions in soluble
versus immobilized states has been diffi-
cult to obtain, because soluble chemo-
kines are readily removed by conventional
histological analysis. Thus, a genetic
interference with chemokine immobiliza-
tion has been necessary in order to
dissect the significance of immobilization
for particular adhesive and migratory
processes.
Leukocyte extravasation from blood
involves sequential chemoattractant-
mediated signals. Chemokines stably im-
mobilized on surface proteoglycans on
the luminal surface of endothelial cells
were suggested to play a pivotal role in in-tegrin-mediated arrest of rolling leukocytes
(Ley et al., 2007). Additional chemokine
signals were suggested to promote crawl-
ing of leukocytes across endothelium,
protrusion, and encounter of abluminal
chemokines (Ley et al., 2007). Chemokine
immobilizationonvascularendothelial cells
and adherent platelets was suggested to
be critical not only to prevent their dilution
by blood flow but also to facilitate localized
signaling to integrins on rolling leukocytes.
In addition, stroma-immobilized chemo-
kines efficiently promote motility of
lymphocytes and dendritic cells (DCs) in
specificareasof lymphoid tissues (Bajenoff
et al., 2006). However, it is still unclear
whether chemokines that direct leukocyte
motility and chemotaxis in various intersti-
tial spaces as well as across epithelial
barriers operate in their soluble or immobi-
lized states (Schumann et al., 2010).
Most chemokines share a carboxyl
terminus stretch of positively chargedresidues that recognize heparan sulfate
(HS) GAGs with moderate affinities
(Proudfoot, 2006; Rot and von Andrian,
2004). HS GAGs are ubiquitous and
structurally diverse macromolecules that
interact with many cytokines, growth
factors, and extracellular matrix (ECM)
components. In vitro and in vivo studies
on leukocyte interactions with various
endothelial cells have suggested that
many chemokines immobilize, and at
times also oligomerize on, HS GAGs
(Proudfoot, 2006). The first in vivo
involvement of endothelial heparan sul-
fate in inflammation was genetically
supported by elegant endothelial-tar-
geted ablation of the enzyme required
for N-sulfation of HS GAGs (Wang et al.,
2005). Attenuated neutrophil infiltration
to sites of inflammation was reported
in these mice but was attributed to
combined inhibition of chemokine trans-
cytosis across endothelial cells,
